Non-alcoholic Fatty Liver Disease
Concept
Vocabulary Service
Overview
subject area of
-
AMPK as a Therapeutic Target for Treating Metabolic Diseases Academic Article
-
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models Academic Article
-
Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood Academic Article
-
Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight Academic Article
-
Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys Academic Article
-
Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats Academic Article
-
Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes Academic Article
-
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients Academic Article
-
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways Academic Article
-
Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study Academic Article
-
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis Academic Article
-
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease Academic Article
-
Direct
AMPK
Activation Corrects
NASH
in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis Academic Article
-
Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials Academic Article
-
Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex‐specific manner Academic Article
-
Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation Academic Article
-
Fluoxetine-induced hepatic lipid accumulation is linked to elevated serotonin production Academic Article
-
Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ
12,14
PGJ
2 Academic Article
-
Fructose, pregnancy and later life impacts Academic Article
-
Fructose-Containing Sugars, Blood Pressure, and Cardiometabolic Risk: A Critical Review Academic Article
-
GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury Academic Article
-
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease Academic Article
-
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China) Academic Article
-
High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway Academic Article
-
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes Academic Article
-
Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis Academic Article
-
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis Academic Article
-
Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia Academic Article
-
Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota Academic Article
-
Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring Academic Article
-
Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure Academic Article
-
NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice Academic Article
-
Nontargeted Serum Lipid Profiling of Nonalcoholic Steatohepatitis by Multisegment Injection–Nonaqueous Capillary Electrophoresis–Mass Spectrometry: A Multiplexed Separation Platform for Resolving Ionic Lipids Academic Article
-
Offspring of Mothers Fed a High Fat Diet Display Hepatic Cell Cycle Inhibition and Associated Changes in Gene Expression and DNA Methylation Academic Article
-
Overstated Associations Between Fructose and Nonalcoholic Fatty Liver Disease Academic Article
-
Reply Academic Article
-
Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease Academic Article
-
Treatment of nonalcoholic fatty liver disease: role of AMPK Academic Article
-
Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease Academic Article
-
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity Academic Article
-
Western diet consumption through early life induces microvesicular hepatic steatosis in association with an altered metabolome in low birth weight Guinea pigs Academic Article
-
[Comparative study of clinicopathological features, and risk factors of advanced fibrosis between genders with non-alcoholic fatty liver disease]. Academic Article